Showing results (1-10 of 147) with videos related to
Sort By:
Pageof 15
Expert Opinion on Therapeutic Targets|March 24, 2012
Targeting VEGF in lung cancerMillie Das, Heather WakeleeTranslational Lung Cancer Research|March 26, 2015
Angiogenesis and lung cancer: ramucirumab prolongs survival in 2(nd)-line metastatic NSCLCMillie Das, Heather WakeleeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Antibodies to vascular endothelial growth factor in non-small cell lung cancerHeather WakeleeClinical Lung Cancer|June 26, 2022
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based RegimensSarah Waliany, Heather Wakelee, Kavitha Ramchandran, et al.JCO Oncology Practice|April 28, 2023
Are We Getting Closer to the Promise of Cure? New Progress and Future Directions in the Treatment of Early-Stage Non-Small-Cell Lung CancerMillie DasCurrent Opinion in Molecular Therapeutics|August 3, 2010
AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancerJoel Neal, Heather WakeleeCurrent Treatment Options in Oncology|July 20, 2007
Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitorsElwyn Cabebe, Heather WakeleeDrugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Sunitinib: a newly approved small-molecule inhibitor of angiogenesisElwyn Cabebe, Heather WakeleeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2021
Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLCSarah Waliany, Han Zhu, Heather Wakelee, et al.Seminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Adjuvant chemotherapy for resected non-small cell lung cancerHeather Wakelee, Laveena ChhatwaniPageof 15